Eisai at a Glance
Eisai Group Worldwide
Eisai's hhc Concept
Innovation
About Eisai
Investors
Sustainability

Sustainability

Making our medicines available to those who need them

30 countries 2.28 billion tablets

Number of countries supplied with lymphatic filariasis treatment
and volume supplied (as of February 2024)

Eisai is promoting initiatives for improving access to medicines to contribute to people in developing and emerging countries

  • Eisai; The First 80 year The History of Eisai